Tech Company Financing Transactions
1nhaler Funding Round
On 11/3/2026, 1nhaler received $3 million in financing from Archangels, British Business Bank and Scottish Enterprise.
Transaction Overview
Company Name
Announced On
11/3/2026
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to facilitate late-stage development of its lead product, 1nhaler Salbutamol, complete the technical transfer of the product into contract manufacturing for clinical trial material, progress a small clinical trial targeted for late 2027 regulatory filing, and advance business development discussions.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1(2f3) Jessfield Terrace
Edinburgh, Scotland, EH6 4JR
UK
Edinburgh, Scotland, EH6 4JR
UK
Phone
Undisclosed
Email Address
Overview
1inhaler operates as a developer of drug delivery device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lisa McMyn
Chief Scientific Officer
Helen Muirhead
Browse more venture capital transactions:
Prev: 11/3/2026: Clark Technologies venture capital transaction
Next: 11/3/2026: Trajectory venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs